Recursion, Roche, and its Genentech subsidiary have unveiled a whole-genome map of specialized microglial immune cells that they plan to use toward revealing significant new targets in ...

Recursion Pharmaceuticals (NASDAQ: RXRX) is a relatively small player in the biotech industry. The same is true in artificial ...

In this paper we consider the problem of fitting, recursively in time, an autoregressive moving average (ARMA) model to time series data where outliers may be present. Although many recursive ...

Nancy L. Stokey, Edward C. Prescott, Robert E. Lucas Jr. This rigorous but brilliantly lucid book presents a self-contained treatment of modern economic dynamics. Stokey, Lucas, and Prescott develop ...

In this article, we will be taking a look at the Top 10 AI-Powered Biotech Stocks to Buy Now. Recursion Pharmaceuticals, Inc. is one of them. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), a ...

This Q&A is part of a weekly series of posts highlighting common questions encountered by technophiles and answered by users at Stack Exchange, a free, community-powered network of 100+ Q&A sites.

Forbes contributors publish independent expert analyses and insights. I write about the business of healthcare. This article is more than 5 years old. Chris Gibson, Co-Founder & CEO, Recursion ...